Chen; June

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; June.The latest application filed is for "intravaginal system for menstrual cycle monitoring".

Company Profile

3.22.23

Chen; June - Sandy UT
Chen; June - San Juan Capistrano CA
- San Juan Capistrano CA US
Chen; June - Via Los Arboles CA US
Chen; June - San Juan Cupistrano CA
Chen; June - Hsinchu TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intravaginal System For Menstrual Cycle Monitoring App 20210022661 - Ryan; Jeanna ; et al.	2021-01-28
Hypotensive lipid and timolol compositions and methods of using same Grant 10,045,997 - Chen , et al. August 14, 2	2018-08-14
Cannabinoid-2 agonists Grant 9,670,216 - Chen , et al. June 6, 2	2017-06-06
Hypotensive Lipid And Timolol Compositions And Methods Of Using Same App 20170112853 - Chen; June ; et al.	2017-04-27
Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use Grant 9,579,328 - Schiffman , et al. February 28, 2	2017-02-28
Prostaglandin And Vasoconstrictor Pharmaceutical Compositions And Methods Of Use App 20160354383 - SCHIFFMAN; RHETT M. ; et al.	2016-12-08
Hypotensive lipid and timolol compositions and methods of using same Grant 9,474,760 - Chen , et al. October 25, 2	2016-10-25
Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use Grant 9,248,135 - Schiffman , et al. February 2, 2	2016-02-02
Cannabinoid-2 Agonists App 20150284400 - Chen; June ; et al.	2015-10-08
Cannabinoid-2 agonists Grant 9,062,004 - Chen , et al. June 23, 2	2015-06-23
Hypotensive Lipid And Timolol Compositions And Methods Of Using Same App 20150150880 - Chen; June ; et al.	2015-06-04
Hypotensive lipid and timolol compositions and methods of using same Grant 8,906,907 - Chen , et al. December 9, 2	2014-12-09
Hypotensive Lipid And Timolol Compositions And Methods Of Using Same App 20140051704 - Chen; June ; et al.	2014-02-20
Hypotensive lipid and timolol compositions and methods of using same Grant 8,629,140 - Chen , et al. January 14, 2	2014-01-14
Hypotensive lipid and timolol compositions and methods of using same Grant 8,618,093 - Chen , et al. December 31, 2	2013-12-31
Hypotensive lipid and timolol compositions and methods of using same Grant 08618093 -	2013-12-31
Prostaglandin And Vasoconstrictor Pharmaceutical Compositions And Methods Of Use App 20130281454 - SCHIFFMAN; RHETT M. ; et al.	2013-10-24
Abnormal cannabidiols as agents for lowering intraocular pressure Grant 8,420,637 - Chen , et al. April 16, 2	2013-04-16
Cannabinoid-2 Agonists App 20130059848 - Chen; June ; et al.	2013-03-07
Abnormal Cannabidiols As Agents For Lowering Intraocular Pressure App 20110269715 - Chen; June ; et al.	2011-11-03
Abnormal cannabidiols as agents for lowering intraocular pressure Grant 7,968,711 - Chen , et al. June 28, 2	2011-06-28
Abnormal cannabidiols as agents for lowering intraocular pressure Grant 7,718,830 - Chen , et al. May 18, 2	2010-05-18
EP2 receptor agonists for treating glaucoma Grant 7,696,235 - Woodward , et al. April 13, 2	2010-04-13
Abnormal Cannabidiols As Agents For Lowering Intraocular Pressure App 20100010027 - Chen; June ; et al.	2010-01-14
Abnormal Cannabidiols as agents for lowering intraocular pressure Grant 7,618,966 - Chen , et al. November 17, 2	2009-11-17
Prostaglandin EP.sub.4 antagonists Grant 7,612,082 - Wheeler , et al. November 3, 2	2009-11-03
Abnormal cannabidiols as agents for lowering intraocular pressure Grant 7,612,101 - Chen , et al. November 3, 2	2009-11-03
Hypotensive Lipid And Timolol Compositions And Methods Of Using Same App 20090181969 - CHEN; JUNE ; et al.	2009-07-16
Abnormal Cannabidiols as agents for lowering intraocular pressure App 20070249602 - Chen; June ; et al.	2007-10-25
Abnormal Cannabidiols as agents for lowering intraocular pressure App 20070249581 - Chen; June ; et al.	2007-10-25
Abnormal cannabidiols as agents for lowering intraocular pressure App 20070249731 - Chen; June ; et al.	2007-10-25
Abnormal Cannabidiols As Agents For Lowering Intraocular Pressure App 20070249596 - Chen; June ; et al.	2007-10-25
EP2 receptor agonists for treating glaucoma App 20070049625 - Woodward; David F. ; et al.	2007-03-01
Prostaglandin EP4 antagonists App 20060094742 - Wheeler; Larry A. ; et al.	2006-05-04
Low voltage differential signaling device with feedback compensation Grant 7,030,656 - Lo , et al. April 18, 2	2006-04-18
Abnormal cannabidiols as neuroprotective agents for the eye App 20050282912 - Chen, June ; et al.	2005-12-22
Abnormal cannabidiols as agents for lowering intraocular pressure App 20050282913 - Chen, June ; et al.	2005-12-22
Abnormal cannabidiols as agents for lowering intraocular pressure App 20050282902 - Chen, June ; et al.	2005-12-22
Low voltage differential signaling device with feedback compensation App 20040150634 - Lo, Hua-Jan ; et al.	2004-08-05
Hypotensive lipid and timolol compositions and methods of using same App 20030069286 - Chen, June ; et al.	2003-04-10
Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives Grant 5,661,178 - Chen , et al. August 26, 1	1997-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.